Objective
biosurfit have developed an In Vitro Diagnostic (IVD) tool - the spinitCompanion - enabling the testing for a wide range of blood parameters that are needed for urgent and accurate diagnosis in order to deliver the correct treatment for chronic diseases. The solution comprises an analyser, a smartphone application and disposable cartridges to process a single drop of blood and provide doctors with real time results. biosurfit's user-friendly device allows for multiple panel blood assays - near or at the patient Point of Care (PoC) - with the use of one single platform. This solution is cheaper and significantly faster than performing such tests recurrently, as chronic conditions require, in a standard lab setting, Furthermore the technology provides a high level of accuracy (comparable to established central lab tests), and quantifies the presence of specific clinical parameters in less than 10 minutes. biosurfit’s solution responds to two main objectives outlined in the EU Health Strategy, which cover both relevant economic and social aspects: 1) Improve the sustainability and efficiency of social and healthcare system 2) Keeping people healthy and active for longer has a positive impact on productivity and
competitiveness. The spinitCompanion fully fits with biosurfit’s overall strategy with an innovative product that leverages on the same flagship technology platform - spinit® reader - already on the market and now protected with 20 independent patents. biosurfit’s vision and main goal is to deliver blood analysis testing to the public, removing its reliance on centralised laboratories and long waiting times both for patients and doctors. In this scenario, the SME Instrument project will enable an important step in achieving EU regulation compliance and the development of a full manufacturing and commercialization plan, and strong IP/marketing strategy based on in-depth analysis of European markets.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences clinical medicine cardiology cardiovascular diseases
- medical and health sciences basic medicine neurology stroke
- engineering and technology medical engineering medical laboratory technology laboratory samples analysis
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3.1.3. - Treating and managing disease
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
3810 744 AVEIRO
Portugal
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.